# FDA Inspection 1120492 - KEDPLASMA LLC - March 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/kedplasma-llc/1d2660cb-71db-4bb5-81ee-5b741db67e6f
Source feed: FDA_Inspections

> FDA Inspection 1120492 for KEDPLASMA LLC on March 12, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120492
- Company Name: KEDPLASMA LLC
- Inspection Date: 2020-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 987180 - 2016-09-15](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/3b5a3b90-d6b0-4327-9d30-636e6cf15b28)
- [FDA Inspection 843951 - 2013-08-14](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/4860077d-b321-4f01-8153-dece247322db)
- [FDA Inspection 740957 - 2011-08-24](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/c639f4b3-a9e9-4ec1-843d-7f93998d213e)

Company: https://www.keypedia.com/companies/kedplasma-llc/2db07c99-a7d0-429f-a60a-244f4762fa73

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d